#1 Clinical Trials Search in Europe

Clinical Trials By Country

Explore medical research studies available worldwide

Austria

1000+ Trials
100+ centers
Latest trial:
A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

Belgium

2000+ Trials
300+ centers
Latest trial:
Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

Bulgaria

800+ Trials
400+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Croatia

200+ Trials
61 centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Cyprus

16 Trials
5 centers
Latest trial:
Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

Czechia

1400+ Trials
600+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Denmark

1400+ Trials
100+ centers
Latest trial:
Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

Estonia

100+ Trials
45 centers
Latest trial:
A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Finland

500+ Trials
100+ centers
Latest trial:
Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

France

4000+ Trials
900+ centers
Latest trial:
Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

Germany

3400+ Trials
2100+ centers
Latest trial:
A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

Greece

1000+ Trials
100+ centers
Latest trial:
A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

Guadeloupe

2 Trials
1 centers
Latest trial:
Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

Hungary

1200+ Trials
300+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Iceland

29 Trials
2 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

India

0 Trials
1 centers

Ireland

400+ Trials
46 centers
Latest trial:
Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Israel

0 Trials
1 centers

Italy

3500+ Trials
500+ centers
Latest trial:
A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

Latvia

100+ Trials
81 centers
Latest trial:
Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Lithuania

200+ Trials
78 centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Luxembourg

30 Trials
4 centers
Latest trial:
A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

Norfolk Island

0 Trials
1 centers

Norway

600+ Trials
100+ centers
Latest trial:
Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Poland

2500+ Trials
1600+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Portugal

700+ Trials
85 centers
Latest trial:
Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Réunion

2 Trials
6 centers
Latest trial:
Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

Romania

700+ Trials
400+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Slovakia

400+ Trials
300+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Slovenia

99 Trials
26 centers
Latest trial:
RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Spain

4200+ Trials
500+ centers
Latest trial:
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Sweden

1000+ Trials
100+ centers
Latest trial:
Evaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer

The Netherlands

2200+ Trials
200+ centers
Latest trial:
Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

United Kingdom

2 Trials
1 centers
Latest trial:
Study of Atropine Sulfate eye drops (0.

United States

2 Trials
2 centers
Latest trial:
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease